Animal Models Core

动物模型核心

基本信息

  • 批准号:
    10677590
  • 负责人:
  • 金额:
    $ 59.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-01 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

CORE C – ANIMAL MODELS PROJECT SUMMARY Cystic fibrosis (CF) is a common autosomal recessive disease caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). CF affects multiple organs, including lungs, pancreas, intestine, liver, sweat glands, gallbladder, and the male genital tract. Airway infection and inflammation currently cause most of the morbidity and mortality. Although several therapies have improved the lives of patients, current treatments are inadequate and CF remains a lethal disease. Our knowledge about the pathogenesis of the disease, its progression, and the state of the neonatal lung is inadequate. These gaps in our knowledge have hindered attempts to develop better treatments and preventions for CF lung disease. A major impediment to addressing these issues had been limitations of animal models. Although mouse strains carrying null and missense CFTR mutations have made enormous contributions, CF mice do not develop the airway or pancreatic disease typically found in humans. We have generated CF ferrets and pigs that replicate many of the key features of human CF disease including intestinal obstruction, exocrine pancreatic destruction, micro-gallbladder, vas deferens abnormalities, focal biliary cirrhosis, congenital airway structural abnormalities, and airway and sinus infection with time. The goals of the Animal Models Core will be: (1) To provide Program investigators with non-CF and CF ferrets and pigs so that they can successfully complete their project aims. (2) To build new genetically engineered CF ferret models that express CFTR in a regulated fashion. (3) To assist projects in carrying out small molecule delivery, the harvesting of biologic samples from live animals (e.g., bronchoalveolar lavage fluid, blood, and microbiological samples), and the care and analysis of study animals. (4) To assist projects in record keeping and coordinate animal usage among projects. The Animal Models Core will function seamlessly through already established interactions with the Project Leaders, Pathology Core, In Vitro Models and Cell Culture Core, and the Administrative Core. The success of the Animal Models Core is ensured because of the commitment, experience, and expertise that the personnel bring to the Core.
核心 C – 动物模型 项目概要 囊性纤维化(CF)是一种常见的常染色体隐性遗传疾病,由编码基因突变引起 囊性纤维化跨膜电导调节器(CFTR)。 CF 影响多个器官,包括肺、 胰腺、肠、肝脏、汗腺、胆囊和男性生殖道。呼吸道感染和 目前,炎症是导致大部分发病和死亡的原因。尽管多种疗法已经改善了 患者的生命,目前的治疗不足,CF 仍然是一种致命的疾病。我们对以下方面的了解 该疾病的发病机制、进展以及新生儿肺部的状态尚不明确。这些差距 我们的知识阻碍了开发更好的治疗和预防 CF 肺病的尝试。一个 解决这些问题的主要障碍是动物模型的局限性。尽管小鼠品系 携带无效和错义 CFTR 突变做出了巨大贡献,CF 小鼠没有发展出 通常在人类中发现的气道或胰腺疾病。我们已经培育出了能够复制的 CF 雪貂和猪 人类 CF 疾病的许多关键特征包括肠梗阻、胰腺外分泌破坏、 微胆囊、输精管异常、局灶性胆汁性肝硬化、先天性气道结构异常、 随着时间的推移,气道和鼻窦也会发生感染。动物模型核心的目标是: (1) 提供程序 研究人员使用非 CF 和 CF 雪貂和猪,以便他们能够成功完成他们的项目目标。 (2) 建立新的基因工程 CF 雪貂模型,以受监管的方式表达 CFTR。 (3) 协助 进行小分子递送、从活体动物(例如, 支气管肺泡灌洗液、血液和微生物样本),以及研究动物的护理和分析。 (4) 协助项目保存记录并协调项目之间的动物使用。动物模型核心 将通过与项目负责人、病理学核心、体外建立的互动无缝运作 模型和细胞培养核心以及管理核心。确保动物模型核心的成功 因为这些人员为核心带来的承诺、经验和专业知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID A STOLTZ其他文献

FATAL LUNG INJURY SECONDARY TO TRIMETHOPRIM-SULFAMETHOXAZOLE
  • DOI:
    10.1016/j.chest.2023.07.1615
  • 发表时间:
    2023-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    HALEY PYSICK;DAVID A STOLTZ
  • 通讯作者:
    DAVID A STOLTZ

DAVID A STOLTZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID A STOLTZ', 18)}}的其他基金

Climate Change and Lung Health Training Program
气候变化与肺部健康培训计划
  • 批准号:
    10556149
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
Testing the Contributions of Airway Submucosal Glands and Surface Epithelia to Lung Health
测试气道粘膜下腺和表面上皮对肺部健康的贡献
  • 批准号:
    10597111
  • 财政年份:
    2022
  • 资助金额:
    $ 59.97万
  • 项目类别:
Animal Models Core
动物模型核心
  • 批准号:
    10024664
  • 财政年份:
    2020
  • 资助金额:
    $ 59.97万
  • 项目类别:
Animal Models Core
动物模型核心
  • 批准号:
    10248526
  • 财政年份:
    2020
  • 资助金额:
    $ 59.97万
  • 项目类别:
Animal Models Core
动物模型核心
  • 批准号:
    10470334
  • 财政年份:
    2020
  • 资助金额:
    $ 59.97万
  • 项目类别:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
气道碱化和重新利用氨丁三醇作为囊性纤维化的治疗方法
  • 批准号:
    10155587
  • 财政年份:
    2017
  • 资助金额:
    $ 59.97万
  • 项目类别:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
气道碱化和重新利用氨丁三醇作为囊性纤维化的治疗方法
  • 批准号:
    9289053
  • 财政年份:
    2017
  • 资助金额:
    $ 59.97万
  • 项目类别:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
气道碱化和重新利用氨丁三醇作为囊性纤维化的治疗方法
  • 批准号:
    9918957
  • 财政年份:
    2017
  • 资助金额:
    $ 59.97万
  • 项目类别:
Airway Goblet Cells: Friend or Foe?
气道杯状细胞:朋友还是敌人?
  • 批准号:
    8355114
  • 财政年份:
    2012
  • 资助金额:
    $ 59.97万
  • 项目类别:
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity
Paraoxonase-2 S311C 多态性改变糖基化和内酯酶活性
  • 批准号:
    8110743
  • 财政年份:
    2010
  • 资助金额:
    $ 59.97万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了